AtaiBeckley (STU:B72) Scaled Net Operating Assets: -0.10 (As of Mar. 2026)


STU:B72 AtaiBeckley Inc STU:B72
51 GF Score
Price €3.45
GF Value €6.32
! 4 Warning Signs
View Full Analysis

What is AtaiBeckley Scaled Net Operating Assets?

AtaiBeckley STU:B72 51 Scaled Net Operating Assets is -0.10 as of Mar. 2026. GuruFocus rates STU:B72 with a GF Score™ of 51/100 and a GF Value™ of €6.32. The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

AtaiBeckley's operating assets for the quarter that ended in Mar. 2026 was €29.51 Mil. AtaiBeckley's operating liabilities for the quarter that ended in Mar. 2026 was €55.45 Mil. AtaiBeckley's Total Assets for the quarter that ended in Dec. 2025 was €249.99 Mil. Therefore, AtaiBeckley's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was -0.10.

AtaiBeckley Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for AtaiBeckley's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AtaiBeckley Scaled Net Operating Assets Chart

AtaiBeckley Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.24 0.02 0.27 0.28 -0.18

AtaiBeckley Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.27 0.25 -0.13 -0.10

STU:B72 vs GLUE, NUVB, BHVN: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, AtaiBeckley's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AtaiBeckley Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AtaiBeckley's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where AtaiBeckley's Scaled Net Operating Assets falls into.


STU:B72
51GF Score
AtaiBeckley Inc STU:B72
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AtaiBeckley Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

AtaiBeckley's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(31.327-58.628)/152.215
=-0.18

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=249.985 - 218.658
=31.327

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=60.397 - 1.538 - 0.231
=58.628

AtaiBeckley's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(29.506-55.445)/249.985
=-0.10

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=229.119 - 199.613
=29.506

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=57.175 - 1.462 - 0.268
=55.445

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -0.10 mean?
AtaiBeckley (STU:B72) has a Scaled Net Operating Assets of -0.10 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on AtaiBeckley and its competitors.
Is AtaiBeckley's Scaled Net Operating Assets too high?
AtaiBeckley's current Scaled Net Operating Assets is -0.10. Overall, AtaiBeckley has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does AtaiBeckley's Scaled Net Operating Assets compare to GLUE and NUVB?
AtaiBeckley's Scaled Net Operating Assets of -0.10 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on AtaiBeckley and its competitors. AtaiBeckley's current Scaled Net Operating Assets is -0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AtaiBeckley stock overvalued right now?
AtaiBeckley (STU:B72) has a current Scaled Net Operating Assets of -0.10. The stock's GF Value™ is €6.32, compared to a current price of €3.45 — trading 45.5% below its estimated fair value. The current Scaled Net Operating Assets is -0.10. AtaiBeckley's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For AtaiBeckley (STU:B72), the current Scaled Net Operating Assets is -0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AtaiBeckley (STU:B72) Overvalued in 2026?

Based on GuruFocus' analysis, AtaiBeckley stock appears to be undervalued. The current stock price of €3.45 is trading 45.5% below its estimated GF Value™ of €6.32.

Key valuation signals for STU:B72:

  • Scaled Net Operating Assets: -0.10
  • GF Value™: €6.32 vs. price of €3.45 (45.5% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the STU:B72 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AtaiBeckley Business Description

Other Exchanges ATAI:USAB72:Germany
Address 250 West 34th Street, New York, NY, USA, 10119
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
51GF Score

Get the complete analysis for STU:B72

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.45
Price
€6.32
GF Value